In this webinar, “The Emerging Role of Circulating Tumor DNA in Gastrointestinal Stromal Tumor”, Dr. Bialick discussed recent data looking at treatment outcomes based off KIT resistant mutations identified by circulating tumor DNA in patients with GIST. Patient advocate & caregiver Stacey Stevens joined the conversation to share her and her husband Fate’s perspective on testing.
Biomarker.Mutational Testing Resources:
liferaftgroup....
How to get biomarker testing (free for some patients):
liferaftgroup....
Donate to #GISTresearch: liferaftgroup....
GIST Education Resources: liferaftgroup....
8 сен 2024